Dror Bashan

Insider Reports History

Location
Carmiel, Israel
Signature
/s/ Joseph R. Magnas, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Dror Bashan:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Protalix BioTherapeutics, Inc. PRESIDENT AND CEO, Director Common Stock 2.34M $3.63M $1.55 Sep 3, 2025 By Trust
Protalix BioTherapeutics, Inc. PRESIDENT AND CEO, Director Common Stock 133K $205K $1.55 Sep 3, 2025 Direct
Protalix BioTherapeutics, Inc. PRESIDENT AND CEO, Director Stock Option (Right to Buy) 340K Sep 3, 2025 Direct

Insider Reports Filed by Dror Bashan

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PLX Protalix BioTherapeutics, Inc. Sep 3, 2025 2 $0 4 Sep 4, 2025 PRESIDENT AND CEO, Director
PLX Protalix BioTherapeutics, Inc. Oct 19, 2023 2 $90.5K 4 Oct 20, 2023 PRESIDENT AND CEO, Director
PLX Protalix BioTherapeutics, Inc. Aug 15, 2023 1 $0 4 Aug 17, 2023 President and CEO, Director
PLX Protalix BioTherapeutics, Inc. Apr 1, 2023 1 $0 4 Apr 3, 2024 PRESIDENT AND CEO, Director
PLX Protalix BioTherapeutics, Inc. Sep 7, 2022 1 $0 4 Sep 9, 2022 President and CEO, Director
PLX Protalix BioTherapeutics, Inc. Apr 11, 2022 1 $102K 4 Apr 13, 2022 President and CEO, Director
PLX Protalix BioTherapeutics, Inc. Feb 25, 2022 1 $0 4 Feb 28, 2022 President and CEO, Director